Pharmafile Logo

Protagen AG

Protagen Inks License Agreement with Inova Diagnostics for its proprietary BICD2 Biomarker

San Diego, USA & Dortmund, Germany - 11th August, 2016 - PROTAGEN AG, a leading specialist in the development of novel diagnostic tests and companion diagnostics in the autoimmune field, and Inova Diagnostics, a global leader in the development and commercialization of in-vitro diagnostic systems and reagents for autoimmune diseases, have signed a semi-exclusive license...

Protagen AG Appoints Bernhard Kirschbaum as New Chairman and Oliver Schacht as New Board Member

Dortmund, Germany - 20th July, 2016 - Protagen AG, a leading specialist in the development of novel diagnostic tests and companion diagnostics (CDx) in the autoimmune field, today announced that Dr. Oliver Schacht, CEO of Curetis N.V., Holzgerlingen, has joined the companyís Supervisory Board. Additionally, Dr. Bernhard Kirschbaum, former Merck Pharma Executive and member of...

Protagen launches first CE marked diagnostic assays Multilisa CENP-B and Scl-70 for the diagnosis of Systemic Sclerosis

Dortmund, Germany - 31st May 2016 - Protagen AG, a leading specialist in the development of novel diagnostic tests and companion diagnostics in the autoimmune field, today announced the launch of its first CE marked diagnostic assays Multilisa CENP-B and Multilisa Scl-70 ELISA to aid in the diagnosis of Systemic Sclerosis (SSc). The Protagen Multilisa...
https://protagen.com
info@protagen.com
Protagen AG, Otto-Hahn-Str. 15 4422, Dortmund, Germany

+49 231 9742 6300